Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
View from the Thoraxcenter: What's Hot at AHA 24?
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 1 year ago
Explore the cardiovascular breakthroughs shaping AHA 2024!Join renowned experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) as they preview the most impactful late-breaking studies poised to make waves at this year’s AHA Conference. Dive into their expert analysis and gain key insights into the studies that are set to drive the future of cardiovascular… View more

Intervention

Prevention & Chronic Conditions
Benefits of Spironolactone: Win Ratio Analysis of the TOPCAT Trial
Author(s): Dung Viet Nguyen , Hoai Thi Thu Nguyen Added: 6 months ago

Heart Failure
Start date: Sep 01, 2024 End date: Sep 01, 2024
Radcliffe Medical Education is hosting a symposium entitled 'The Bigger Picture: An Expert Assessment on the True Impact of ATTR-CM' at 12:30 UCT+1 on Sunday 1 September 2024 in the Prague Room atESC 2024, ExCel Centre, London, UK.OverviewProf Julian Gillmore (University College London, London, UK) will lead a distinguished faculty in an upcoming CME-accredited session. The faculty includes Dr… View more

Heart Failure
Apelin/APJ and Incretin Therapy in Heart Failure
Author(s): Dominic Marcel Alfonso Added: 1 month ago

MI/ACS

Heart Failure
HFA 24: The TELESAT Study
Author(s): Nicolas Girerd Added: 1 year ago
HFA 2024 — Investigator, Prof Nicolas Girerd (University Hospital of Nancy, FR) joins us to discuss the findings from the TELESAT study (NCT06312501).This multicenter observational longitudinal cohort study investigated whether a Remote Patient Monitoring (RPM) program (Satelia®Cardio, Satelia) is able to prevent cardiac decompensation by detecting weak signals of decompensation early in patients… View more

Digital Health

Heart Failure
Cardiomyopathies: Management of Cardiomyopathies with Dr Michelle Kittleson
Author(s): Michelle Kittleson Added: 8 months ago
Learn about the management of HFrEF and HFpEF from Dr Michelle Kittleson (Cedars-Sinai Heart Institute, Los Angeles, US).This two-part video lecture series, part of Women As One's CLIMB® 2025 Skills Training Program, provides a comprehensive overview of key treatments and therapy approaches to cardiomyopathies.In this lecture, Dr Kittleson provides an in-depth review of the management of HFrEF… View more

Heart Failure
GDMT & Outcomes in HFrEF: Physician-led Multicentre Experience from Sarawak
Author(s): Rebecca Su Li Chew , Bui Khiong Chung , Hwei Sung Ling , et al Added: 3 weeks ago

Cardiovascular Renal Metabolic

Guidelines & Statements
ESC 25: The ODYSSEY-HCM Study
Author(s): Milind Y Desai Added: 7 months ago
ESC Congress 2025 - ODYSSEY-HCM finds no improvements in patients with non-obstructive cardiomyopathy when treated with mavacamten.Dr Milind Desai (Cleveland Clinic, US) joins us to discuss findings from the ODYSSEY-HCM trial, evaluating the safety, tolerability, and efficacy of mavacamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy.The ODYSSEY-HCM study was a… View more

Heart Failure
ESC HF 25: CRISPR in ATTR-CM: Hereditary vs Wild-Type
Author(s): Marianna Fontana Added: 11 months ago
ESC HF 25 - A study investigating CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy demonstrated favourable safety and tolerability, with consistent reductions in serum TTR in both wild-type and variant disease.Prof Marianna Fontana (University College London, UK) joins us to discuss the key findings from a two-part, open-label, phase 1 study investigating the treatment effect,… View more

Heart Failure
Undiagnosed Sleep Apnoea Linked to Adverse Myocardial Remodelling in Hypertrophic Cardiomyopathy
Added: 6 months ago Source:  Radcliffe Cardiology
Sleep-disordered breathing (SDB), a condition mediated by intermittent hypoxaemia and autonomic dysregulation, is a well-established contributor to cardiovascular morbidity. A new prospective cohort study suggests that patients with hypertrophic cardiomyopathy (HCM) are particularly at risk, revealing a high prevalence of previously undiagnosed SDB in this population. The research links the… View more

Imaging & Diagnostics

Heart Failure